The relationship between hypoxia, inflammation, and airway obstruction with carotid intima-media thickness in Chronic Obstructive Pulmonary Disease (COPD)
Abstract
The present study aimed to determine whether there is a relationship between intima-media thickness (IMT) changes in peripheral vessels (carotid and vertebral artery) and inflammatory mediators (C-reactive protein (CRP), leucocytes, etc.), artery blood gas changes and airway obstruction in COPD patients. This study included 60 patients with COPD and 40 healthy control subjects. We used the GOLD criteria for COPD diagnosis. The patient group differentiated according to arterial blood gas values and the presence or absence of pulmonary failure, and its type if any was present. In all patients and control group members, blood leucocytes and CRP values were measured. The carotid, vertebral artery thickness, and total cerebral blood flow were measured using a Doppler USG device and standardized 7 MHz linear transducer. There was no significant relationship between age, sex, body mase index (BMI) and intima-media thickness between the two groups. In the present study, we found out that the CRP levels were higher in COPD patients than in the control group. In progressive COPD patients, CRP levels were the highest. Furthermore, we found out the CIMT was higher in COPD patients compared to the control group. In conclusion, the CIMT and atherosclerosis risk increased in COPD patients. Systemic inflammation causes a higher carotid intima-media thickness in COPD patients. This finding was used as an early risk factor for cardiovascular disease. Doppler USG was used to identify a carotid artery pathology early. Systematic inflammation continuing during a stable period causes increased carotid artery intima-media thickness. This entity plays a role in atherosclerosis etiology.
Keywords
References
- 1- Bartu Saryal S, Acıcan T. (eds) Epidemiyoloji ve risk faktörleri. In: Güncel Bilgiler Işığında KOAH, Bilimsel Tıp Kitabevi, Ankara 12-32, 2003.
- 2- Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Iniative for chronic obstructive lung disease (GOLD) Workshop summary. Am J Respir Crit Care Med, 163:1256 -1276, 2001
- 3- Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thorac. Soc, 2: 8-11, 2005
- 4- O’Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis. Am. J. Cardiol, 90:18-21, 2002.
- 5- Fabri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G ve ark. Differences in airway inflamation in patients with fixed airflow obstruction due to asthma or chronic obstructive lung disease. Am J Respir Crit Care Med, 167: 418-424, 2003.
- 6- Global Initiative For Chronic Obstructive Lung Disease (GOLD) 4: 24-30, 2008.
- 7- Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med, 340:115-126, 1999.
- 8- Torres JP ve ark. C-reactive protein levels and clinically important predictive outcomes in stable COPD patiens. Eur Respir J, 27: 902–907, 2006.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Publication Date
June 30, 2019
Submission Date
March 15, 2019
Acceptance Date
June 27, 2019
Published in Issue
Year 2019 Volume: 41 Number: 2